Zhangzhou Pientzehuang Pharmaceutical Co Ltd

Return on Assets, %

19

-2.7

Net income margin, %

31.4

2.8

EBITDA margin, %

36.8

10.8

Debt to Equity, %

8

19.2

Intangible assets and goodwill, %

1.9

3.6

Revenue CAGR 3Y, %

14.9

8.5

Total Equity change 1Y, %

8.4

0

Revenue Y, % chg

6

0.5

P/E

46.2

22.7

P/BV

10

1.5

P/S

13.5

2.3

EV/S

13.3

2.4

EV/EBITDA

39.8

7.4

Average Analyst recommendation

Hold

Hold

Average upside forecasts, %

44.1

51.3

Forward P/E

34.7

15.6

Dividend Yield, %

0.5

1.7

Forward Dividend Yield, %

0.1

0.2

Expected dividend per share

0.2

0

Payout Ratio, %

27.9

30.3

Dividend Ex Date

2023-07-12